The PD-L1 metabolic interactome intersects with choline metabolism and inflammation
Abstract Background Harnessing the power of the immune system by using immune checkpoint inhibitors has resulted in some of the most exciting advances in cancer treatment. The full potential of this approach has, however, not been fully realized for treating many cancers such as pancreatic and breas...
Main Authors: | Jesus Pacheco-Torres, Marie-France Penet, Yelena Mironchik, Balaji Krishnamachary, Zaver M. Bhujwalla |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Cancer & Metabolism |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40170-021-00245-w |
Similar Items
-
Effect of pantethine on ovarian tumor progression and choline metabolism
by: Marie-France Penet, et al.
Published: (2016-11-01) -
PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation
by: Jesus Pacheco-Torres, et al.
Published: (2021-02-01) -
VEGF Overexpression Significantly Increases Nanoparticle-Mediated siRNA Delivery and Target-Gene Downregulation
by: Shanshan Tan, et al.
Published: (2022-06-01) -
Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy
by: Zhihang Chen, et al.
Published: (2016-02-01) -
Ascites Volumes and the Ovarian Cancer Microenvironment
by: Marie-France Penet, et al.
Published: (2018-12-01)